<div id="readability-page-1"><p>RadNet, Inc. (NASDAQ:RDNT - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $72.58, but opened at $65.78. RadNet shares last traded at $67.29, with a volume of 1,011,487 shares traded.</p><h2>Analyst Ratings Changes</h2><ul><li>Biotech &amp; Healthcare Meet AI: Stocks Soar On Innovation Potential</li></ul><p>A number of brokerages recently issued reports on RDNT. B. Riley lifted their price objective on shares of RadNet from $71.00 to $87.00 and gave the company a &#34;buy&#34; rating in a research note on Monday, December 1st. Barclays lifted their price target on RadNet from $79.00 to $86.00 and gave the company an &#34;overweight&#34; rating in a research note on Thursday, November 13th. Truist Financial upped their price objective on RadNet from $81.00 to $90.00 and gave the stock a &#34;buy&#34; rating in a research report on Wednesday, November 12th. Weiss Ratings  reiterated a &#34;sell (d-)&#34; rating on shares of RadNet in a research report on Monday, December 8th. Finally, Raymond James Financial  reissued a &#34;strong-buy&#34; rating and set a $95.00 target price on shares of RadNet in a research note on Friday, November 14th. One analyst  has rated the stock with a Strong Buy rating, five have assigned  a Buy rating, one  has assigned  a Hold rating and one  has issued  a Sell rating to the company. Based on data from MarketBeat, RadNet  has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $87.60.</p><p><b>Check Out Our Latest Report on RadNet</b></p><h2>RadNet Trading Down 3.7%</h2><p>The business has a fifty day simple moving average of $78.24 and a 200-day simple moving average of $68.78. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.87 and a current ratio of 1.87. The firm has a market cap of $5.39 billion, a price-to-earnings ratio of -410.98 and a beta of 1.48. </p><p>RadNet (NASDAQ:RDNT - Get Free Report) last announced its quarterly earnings results on Monday, November 10th. The medical research company reported $0.20 EPS for the quarter, missing analysts' consensus estimates of $0.23 by ($0.03). RadNet had a negative net margin of 0.65% and a positive return on equity of 2.52%. The firm had revenue of $522.87 million for the quarter, compared to analyst estimates of $494.19 million. During the same period in the previous year, the business posted $0.18 earnings per share. The business's revenue for the quarter was up 13.4% compared to the same quarter last year.  As a group, equities analysts forecast that  RadNet, Inc. will post 0.56 earnings per share for the current fiscal year. </p><h2>Insider Transactions at RadNet</h2><p>In other RadNet news, CAO Mital Patel sold 25,000 shares of the company's stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $76.06, for a total value of $1,901,500.00. Following the completion of the transaction, the chief accounting officer directly owned 205,138 shares in the company, valued at approximately $15,602,796.28. This represents a 10.86% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In the last ninety days, insiders have sold 50,000 shares of company stock valued at $3,902,254. Corporate insiders own  5.60% of the company's stock. </p><h2>Institutional Trading of RadNet</h2><p>Institutional investors and hedge funds have recently bought and sold shares of the stock. LPL Financial LLC raised its position in  RadNet by 616.4% during the 1st quarter. LPL Financial LLC now owns 45,260 shares of the medical research company's stock worth $2,235,000 after purchasing an additional 38,942 shares during the last quarter.  Nuveen LLC acquired a new stake in shares of  RadNet in the first quarter valued at about $27,422,000.  HighTower Advisors LLC raised its position in shares of  RadNet by 6.2% during the first quarter. HighTower Advisors LLC now owns 9,345 shares of the medical research company's stock worth $465,000 after acquiring an additional 548 shares during the last quarter.  Russell Investments Group Ltd. lifted its stake in shares of  RadNet by 15.0% in the first quarter. Russell Investments Group Ltd. now owns 101,018 shares of the medical research company's stock worth $5,023,000 after acquiring an additional 13,147 shares during the period.  Finally, American Century Companies Inc. lifted its stake in shares of  RadNet by 507.9% in the first quarter. American Century Companies Inc. now owns 1,272,928 shares of the medical research company's stock worth $63,290,000 after acquiring an additional 1,063,516 shares during the period. 77.90% of the stock is currently owned by institutional investors and hedge funds. </p><h2>About RadNet</h2> (Get Free Report)<p>RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than RadNet</li><li>Find and Profitably Trade Stocks at 52-Week Lows</li><li>Western Digital’s Nasdaq-100 Entry Caps Its AI-Driven Comeback</li><li>How to Buy Cheap Stocks Step by Step</li><li>Paramount Threw a Wrench in Netflix's Bid to Acquire Warner Bros.</li><li>3 Home Improvement Stocks that Can Upgrade Your Portfolio</li><li>3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in RadNet Right Now?</h2><p>Before you consider RadNet, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RadNet wasn't on the list.</p><p>While RadNet currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

RDNT

<p>RadNet, Inc. (NASDAQ:RDNT) shares dropped from $72.58 to $65.78 before the market opened on Tuesday, closing at $67.29. Analysts have mixed ratings: B. Riley, Barclays, and Truist Financial gave 'buy' ratings with higher price targets, while Weiss Ratings issued a 'sell' rating. RadNet reported Q3 earnings of $0.20 per share, missing estimates. Insiders sold 50,000 shares recently. Institutional investors hold 77.90% of the stock. RadNet provides outpatient diagnostic imaging services in the U.S.</p>

RadNet (NASDAQ:RDNT) Shares Gap Down - Should You Sell?